NUVA - Earnings call transcript Q3 2019

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Greetings and welcome to the NuVasive, Inc.'s Third Quarter 2019 Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions].

As a reminder, this conference is being recorded.

to Vice conference External President like host, to Affairs. now Hatcher, Suzanne of would turn over the your I Internal and Thank you.

You begin. may

Suzanne Hatcher

accompany earnings IR on release, We've financial Michelle. discussion. The on this Exchange our our you, Welcome Commission. has NuVasive’s also website with posted quarter Thank information been the and filed and to afternoon, is supplemental company's X-K on we which XXXX earnings to website issued Form the earlier posted third call. Securities

Before will which you and results expressed statements. to such today's on correct, we do assumptions, to the that from they materialize or materially remind implied differ expectations by if uncertainties, not begin, I'd be include could like or and cause discussions during which, to forward-looking those other involve current are NuVasive's call risks and statements, factors forward-looking based prove

the NuVasive's of NuVasive described and forward-looking Additional dates. periodic future results update as to information risks are statements with and respective that affect any or and which news releases may no obligation Securities speak in their Exchange uncertainties filings assumes Commission.

operating marketing with call administrative GAAP. Accepted These This include flow, and of accordance discussion financial non-GAAP Accounting and and that our cost per non-GAAP margin, include expenses, also EBITDA. measures earnings gross are to in sales, calculated expenses, Principles sold, a measures or these refer margin, We not measures. share, generally several free as will Generally financial development goods cash of research

accessible supplementary directly website. section news in financial most Relations which financial found are of today's the Investor to may and comparable measures GAAP from NuVasive's the the be information release Reconciliations

and today's Financial Chris Raj Asarpota, on Officer; Officer; Executive Barry, me Chief Link, are President. Chief call Matt Joining

I'd like Chris. call that, to to With over the turn

Chris Barry

spinal reported a are or year. XXXX reported driven we're by as growth with quarter continued growth services year-over-year Thank U.S. products results constant to million $XXX.X execution X.X% X.X% in hardware from primarily afternoon focused as businesses. prior nearly These third the revenue results growth representing and organic well of Early growth attributed currency strong performance this you, Suzanne. new over and commercial solid on double-digit traction international

very I'm XXXX XXXX profitability. the fourth three performed and will on financial top continued results Raj line expectations last with balancing quarters and business details the growth updates over how has in revenue to guidance. pleased raising Based minutes. business, are the the on full confidence Overall, year full with few increased year share additional year-to-date we quarter a in

year spinal several X.X% to discuss revenue quarter me hardware volume this attribute approximately let factors. revenue different over third XX.X%. increased case U.S. growth performance results. Now strong prior with of We meaningful

flat and U.S. XX compared spine market last X% approximately our be estimates to months the internal to to by the continues to the in quarter X% approximately First, months. over growth XX grew stable

In fixation capturing see procedure, addition, position adoption by our well, the of around of both posterior the to pull-through NuVasive's single further starting increased XLIF and driven particularly lateral We're also technologies ALIF franchises procedure. XXXX performed ALIF. full by XXXX exceptionally

high the we on XXXX. in procedure as team did adoption in more clinical and and XX% with Surgeon than XXXX development year-to-date lateral whole training training surgeons remains demand a professional

continued TLIF-A and material to XLIF, and in Modulus also introductions. advanced growth the new XLIF. with portfolio proprietary Our science product notably contributed quarter for Most TLIF-O momentum Cohere

This overall The is in Biologics. products NuVasive an technology over approximately year. on sustaining hardware. revenue in is momentum and X% U.S. to businesses the driven decline well and primarily services and by in continued procedure as enabling our continue procedures in technology down innovation quarter. and balancing in by believe offset clinical Surgical is IOM prior above the U.S. market billings growth key core collections support solid volumes We as uptick

equipment reflected revenue return a fourth remain the to over XXXX. Biologics growth in as confident line Capital was anticipated. year, business the for decline about quarter will continue we that prior revenue X% the to quarter While nominal

continue [ph] for the of remainder sell based complete evaluations we rate year. Pulse and the to While less

as businesses quarter Revenue basis year. constant with with XX.X% specific market international saw currency grew international reported, carryover from approximately growth a the business. into quarter dynamics the XX% from We prior the on associated availability set similar over third second within

than the prior Turning quarter to in XX.X% basis points at margin XX came operating XXXX, third year. for profitability, non-GAAP of higher

over We strategically areas while improving continue consistently investing in profitability for operations. future key to balance growth,

our to to continue required We strides execute rigor against goals. discipline and successfully towards make the acting with

during approach driving goals; accelerate discussed less is focused to developing deformity. invasive technology this enabling favorable adoption, Day NuVasive’s on the further in investing open August, like surgery, increased adoption of key innovation in and markets, to segments open and cervical As Investor three spine

outcomes spine will that NuVasive market the surgeon clinical economic the is leader an to meets innovation that partners predictable, reproducible more and better surgery. enabled of technologies to and and continue bring supports and needs our

the Pulse technology adoption better adopt gained of supporting enable This surgeons, is can procedures at the platform get surgeons Pulse We're disruptive, efficiency approach feedback surgery. on hospitals and spine is the of safer that in more less from greater and designed room. across help of MIS to the working the enabling drive and and surgical procedures. the build postpaid used through feedback clinical allows platforms to from center out thesis us efficient, to body NuVasive’s further operating a evidence evaluations

has evaluation further gathered and period including increased information its has of and to valuable, to-date advancements The been incredibly the functionality robotics. and throughout applications Pulse, led following

is but the the to started impact is in holding and There complete. there pipeline capital POs delivery of are until began availability collected a beta commercial Pulse Since interest, and be XXXX. won't off we phase P&L signed revenue but installation until contract likely for July, on

end capital will guidance. on full along revenue QX, Further shared be XXXX the equipment with year guidance at of

the Pulse early the approval. Mark also institutions milestone An and Germany the platform is hit the initial With on the the international allows wrapping the receiving U.S. the with to important in hospitals CE Netherlands other CE across ready Marked in focus Italy, works. evaluations. deployment up beginning and was platform or geographies with in EU October of betas start the and their several internationally prestigious This deploying academic in

turning of to into other the year, few Now highlights the roadmap for and a remainder XXXX. technology

One on market, trauma system features, exciting designed It unique of a – making new features new unique, developments most will a multiple release in technology offer implant highly the have deformity it NuVasive’s offer The significantly is a treat the cases. alternative devices compared offering. new Cervical to generation, and competitive to of plate. improved portfolio Anterior will

use in in Cervical we'll and technology the portfolio. annual a currently This technology more later QX, Research to innovation meeting Society to we will markets, November. at upcoming preview competitive ties open the where position strategy system clinical directly favorable and investing opportunity are The under limited, represented have of NuVasive’s Spine start an in

businesses in also orthopedic that reconstruction to shift competitive line of lengthening limb to specialized the innovative with standard NuVasive’s continues internal advantage technologies take share, care globally fixation a be and but not only solutions.

with expanded limb nail an Earlier we internal this system, with non-invasive magnetic portfolio a year, to uses precise remote an STRYDE patient's launch of the controller. which external the lengthening technology the technology

expansion. compared Since have launch, weight improved than meaningfully, bearing previous adoption rates product this to the accelerated to capability. better a expected offers systems, been market STRYDE related post-operative with

on current transforming NSO for XXXX standards commercial planned care. focused product Looking has several orthopedic ahead, of launches

organizational SEC. the context the today in give X-K earlier the filed to like release to in I'd announced issued Finally, new structure Form press with

plan, business that organizational and As at learning, strategic CEO of with Investor management I aligned the NuVasive an is functions and spend the structure company's assessing now, strategic for our recently of overall to time natural I’ve different plan. next Coupled is year the structure. listening, Day, a nearly a with and a step shared term team lot implement long organizational the

product together organizational on strategy force of our structure and under updated sales includes leader, one The a implementation current the President technology Link. teams bringing commercial the function, Matt and portfolio

of management to tremendous know Company. business many leading new five well portfolio of tenure Many team delivering This structure the commercial function. in the of This approach the enables functions his years commercial a and Matt to more towards results, from addition and global key operations. U.S. includes holistic overseeing tangible improvements you XX-year with

is further supply and commercial to portfolio to global established chain keep capabilities. manufacturing focused better the improvement. the new a function organization enhances and the our while being excellence This operational continuing to the ability continuous addition, In to planning optimize enable business, on operations globalize and

be be promoted functions Key NuVasive’s Dale of one will Global Head managed to Operations. to operational Wolf, will pleased and Head I'm current announce manufacturing under of leader,

processes. Dale in XXXX efforts, West outputs joined and in the improvement there's the he company's evolved been significant his has Carrollton optimizing streamlining under manufacturing and insourcing facility by and leadership, NuVasive

the in teams roles continue execute set several than years. to NuVasive years of goals profitability with more spent start, the Prior and confident impressed supply we've forth Electric leadership along over leadership his will operations Dale been chain. many and XX General strategy his on next the with that joining operational at from I'm with and Dale to I've manufacturing,

be structure X, effective January of as will new organizational This XXXX.

like organization Now my with to how by the of to today. performance the close turning out back quarter, saying comments pleased the I'd am, formal strong I

multiples and should would further are what the We year. do to several U.S. many the and our and levers quarters This on believe in grow beginning growth next There to. said business. of the are market, we doing we at financial at for we are ability communicated the drive sustainable the I confidence hardware execute commitments help

in priorities January in technology all the that a to accomplish world-class to and leverage. Number three, deliver investment on attractive we reiterate across term. on profitable operating create needed like aspects rigor short be be one, operational focus discipline back disruptive and the outlined three the through Number drive spine an and number growth long and business. leader of innovation. I'd renewed to in And knew excellence two, to execution I continue

I and performance the full year over think in guidance the we're With right XXXX this heading expectations, raise direction. quarter, and

many spine to and technology, surgery focused with on We're started just getting more create patient’s by reproducible shareholder enables outpacing a value lives. with predictable differentiated opportunities that improving others further

QX to Raj like discuss turn I'd to further our that, With performance. over financial to

Rajesh Asarpota

good Thanks everyone. Chris, and afternoon

unless financial information NuVasive.com get to release the call with many remind today's measures covered earnings refer supplemental, regarding non-GAAP financial let Please news basis further started that the reconciliations. Before we for today's otherwise. noted also of financials, me on information non-GAAP on as are a you in

million quarter reflecting constant on with XXXX, For revenue year. was currency $XXX third spinal X.X% million X.X% prior and over strong we U.S. X.X% hardware revenue quarter basis. of of year-over-year reported reported the growth the growth growth for a $XXX.X

first robust XX%. product the growth of volume and than the year procedure a from case more by of be force, and execution half sales in stable continues commercial as driven Performance solid new to introductions,

in increase In [ph] single position MIS surgeon year-over-year adoption, focus lateral driven particular, acceleration continued NuVasive’s reaffirms a in the proceduralization. by on XXXX surgery procedure education instances surgery XX% our

line X% and by the Top and case was clinical million of from pressure a services U.S. solid quarter year. was growth of as volumes, collections. result offset to compared NCS pricing for X.X% down or grew X.X%. NuVasive surgical support year-over-year billing prior $XX.X increased Revenue negative

growth a the from driven discussed IOM by quarter. in primarily offsetting was the Partially NCS pricing competitive in decline products, second

Turning over the X% approximately for business surgical Revenue down third to line. support Biologics the prior within year. quarter was

volumes continue the year. product to is with impacting and Biologics bulk revenues orders grow, of within timing While mix the along pricing

a Pricing product remains pressure on headwind. the lines Osteocel

synthetic we further momentum mitigating aligning with new AttraX, our and DBMs the with However, other factors, biologics of form impact are Osteocel. of competitive gaining line

expected is team million, in currency executing on was In well as with and the light the supported XX.X% still year-over-year fourth XX% revenue growth $XX basis. quarter. constant a of growing dynamics, International these

year, that This with the to last over remainder year-over-year anticipate driven quarter. performance than dock updated the full solid bit in in by year primarily carried I'll limited Asia the availability set softer region was similar and We the anticipated, our Pac in continuing This Spain from offset the was America discuss dynamics U.K., further guidance. Latin which by perform well regions. XXXX a for and growth of EMEA

The third driven savings the the third compared was price inventory manufacturing realized quarter XX.X%, by of non-GAAP of efficiencies, points for XX over XXXX. increase to basis year by prior improvement to margin and XX.X% Moving from an partially quarter offset profitability, in related was gross charges.

flat Ohio the expenses Non-GAAP at plant to were for million the $XXX.X The and prior-year year, coming remaining for period, in compared P&L. to of out the a drive X% benefit the representing revenue. track the continues on quarter of $XXX.X SM&A to is million production XX.X% and

We organizational implemented of continue to the beginning sell at fund year realize streamlining the efficiencies gained strategic to from investments.

other quarter, operational were the packaging supply Within for planned and sterile and investments MDR, projects. made chain as

$XX Pulse period. to line million expenses and Non-GAAP in with research focus core the or grew XX hardware in basis year and compared through quarter projects. with technologies robotics increase the innovation the of Pulse with business points prior and R&D spend R&D X.X% expectations an to development revenue, investing planned remains XX% or enabling along on of

Non-GAAP The previously by the year-over-year XX prior about was expectations and and R&D XX.X% improvement basis also expected mentioned expansion up operating within points by profit previous year. primarily investments. driven margin the margin revenue. hardware the gross to by offset is driven U.S. compared partially This was higher than line

further release year. and Moving million XXXX. from reserve rate This down in that the did not XX%, in other in non-GAAP down primarily effective of P&L, tax re-occur. quarter, the Non-GAAP $X.X that $X.X over basis to year tax a prior on of $X.X occurred due in expense million basis million an a the increase QX a quarter resulting was prior interest XXX net expense the was non-GAAP in points of was

was net or earnings an period to last $X.XX earnings $X.XX share Non-GAAP share non-GAAP year, the non-GAAP of X.X%. non-GAAP compared in per $XX.X or or $X.XX income of per diluted income diluted million million $XX.X same of of increase net

net to compared diluted for per third $X.XX million period same GAAP of results. income the per of year. was share or million earnings the last share $XX.X XXXX diluted or of quarter GAAP Turning in $X.XX to $XX earnings

This which quarter, primarily period MDR stock decrease and of XX.X% non-GAAP excludes compensation year. due and investments margin, the adjustments based EBITDA was to in impact including Adjusted to the same XX.X% chain, non-cash for last in made the was the packaging. sterile compared supply other

expenditures for Finally, year. the income flow as a well compared last business. cash capital $XX.X increase of in an $XX.X This was driven free growth the quarter in million period million support GAAP was by in the to decrease as reduction same to the net

we Based now projected the year billion $X.XX remainder of of the head-wind XXXX. full the The onto expectations approximately the guidance inclusive full for three the end revenue at million. results are now guidance. is on quarters approximately of year expectations of and for year, Moving for outlook guidance first the for $X outlook at previous currency raising high

range basis to X.X% This on guidance X.X% in an of guidance reflects full year to adjusted prior X.X% to prior to X.X% growth a range reported constant of X.X% growth to compared to revenue currency compared X.X% X.X% of or X.X%

XX.X% full year guidance $X.XX range at We guidance $X.XX. range of expected to to of are operating to non-GAAP compared XX.X%. guidance raising to a compared XX.X% range prior the to is margin share to XX.X% The non-GAAP previous to now $X.XX earnings $X.XX per

Overall, are business quarter by business. the the road expected, the looks than international a the just hardware changing driven this U.S. had performance. expected lower strengthened primarily year-to-date is the there expectations different much little get guidance not is slightly in Fourth offsetting performance updated than to

However, additional me the let guidance. you give increased context some around

X% performance year is compared prior X% above to hardware to by business once with increase targets, quarter now for spinal current grow X%. the of driven X% to to again guidance growth between This market rate. exceeding expected U.S. The year-to-date is the

Pulse support guidance IOM expected Surgical along revenue driven to This current be X% the guidance to in with be full of X% now Biologics QX. in expectations not X% that compared in year range U.S. in is product to of to prior performance by recognized growth adjustment lines X%. is will

revenue on guidance expect of in year business, now lowered a to dynamics in to of XX% guidance compared and similar we to full With XX% to America. QX, a international saw backdrop, the basis range the to Latin XX% XX%. growth currency regards prior In constant that is into QX continue Asia-Pacific to as particularly international

this expectations at are rates, our Day. on remain resources is the balancing expectations lower growth term previous than impacting year, This long international expansion Although Investor globe. the efforts we and diligent discussed as being for business, but capital to for the committed across we growth international term short

The in operating impact raises EPS guidance previously I and adjustments mentioned. the of result revenue non-GAAP margin these

previous As remain ramped, QX, margin and third this non-GAAP gross as the included continue investments normal quarter, which trend to guidance we in along spend unchanged increased SM&A seasonality. you was with as in into we saw sequentially expect

us, Q&A. delivering I'd With commitments remain call And and we XXXX. three to the on with that, like solid quarters open up our optimistic for behind financial for

Operator

[Operator Instructions].

from first Matt proceed the of comes line question Our Suisse. with Miksic Please your question. Credit with

question Please next comes line Jennings with Our from Josh of the your question. Cowen. with proceed

Josh Jennings

Spinal to on the growth. on hoping Hi, was results. U.S. good X.X% strong start evening. Congratulations hardware, I

guys You XX% experienced, training give of uptick that in came growth us perhaps nice you've much this new the strong this idea can increased out contribution XXXX. XXXX. added, on on from been customers But my called how really, training through case partially in some that the have is volumes growth question with a you and surgeon

sales your feet the you course and over have force adding the mean, results the numbers. that contribute also, I street then two printed? this still heavily And -- you been to those other year, on the

Matt Link

Matt. with is volume through been that's growth increase the surgeons, course me. balanced of well XXXX. to related Overall existing procedure Excuse from question. customer Appreciate the as as NPI new contribution This was Yes. introduced conversion, the to heavily of a respect

the about and us think surgery. surgery course a extended and XLIF customers you primary us XXXX market lateral lateral with through expansion XXXX portfolio addressable for know focus for the increase of of single the has the As you been XXXX to allows model existing intent as position that with

advancements and continued with growth in in to largely, PEEK as the I our interbody our Modulus including So fixation posterior related of in customer Cohere Porous that's balanced existing a TLIF procedural NPI a new as across said contributor customer attributed our growth as been to portfolio. the the AMS range attraction think to and base, through well healthy with seen I portfolio a offerings, we've

with U.S. additions, So this and a Sales continued to we to year, continue the a our contribution see for with expectations across commercial those organization adds respect have growth force providing see line in as net expected. to

it's a commercial the U.S. both and to organization. the really of So growth been approach balanced portfolio continued growth across really,

Josh Jennings

Great. limited And do just a follow you guys is room or it to one. have for up

Chris Barry

Go Josh. ahead,

Josh Jennings

Chris. -- the nice was updates made commentary system. curious Pulse you just great. guys I if on the Oh, Thanks just some

line. be surgeons a that had guys bunch the out You at down NASS, added of the first surgeon look will robotic their big at event module getting

on Just and wonder on you add if as free color launch you well. from taking could received capabilities specifically the feedback feel you're to beta then any for give color robotics the any on us that the getting Thanks the questions. navigation

Chris Barry

Thanks Josh.

beta You perform generally. bet. system We've we obviously said, Pulse as we continue to for -- we're the would

I overwhelmingly of prime has that interest absolutely We've the base launch, functional think the is are been making course across in over time. customer expect we we're we ready the and our feedback the Clearly, fully that anticipation of which -- for XXXX. gotten full system positive. from sure tremendous

the that was In heard the to you we that -- response NAS robotics, overwhelming very at we, I think know positive. response

unique and to quickly, platform Pulse the to in we've I is think around to of technology the starting built life market taken very think, within of I approach a we've come eyes integrated to bringing customers. a the our what the really uniqueness

don’t feedback the Matt. heard think , been positive. Matt I anything specifically, So but I'll over think to you've it turn has if I

Matt Link

clinical of pathology. applications automation Chris's through see will provide Pulse year if that the broad mentioned and debut the flows with robotics platform surgical you to beta all building to to has along Certainly clinical really really Pulse think and for spine what it at platform continue last software range into cases wide offer alpha picture this and it the XXXX with spine to the of and intent to NAS just Pulse completed as a across further that reinforcement I early a been Josh all in the utility architecture a of we we're of the extensibility support year, that will drive looking the of be the utility. think able with at the NAS, I the of debut, broad Yes, such commentary, and robotics application, positive with

we've with as teams to said, contribution what marketplace platform is continuing as validate can customers to it. we very led to harden pipeline experiences the result and that So got ensure commitments a deliver the of healthy had bring pleased our a our heading of platform work very some Chris our and as to has into internally, against they to XXXX, a comprehensive great and

are So things things are on track.

Operator

Thank you.

the Please from Wells with Our Shagun your with next proceed comes line question. Singh question of Fargo.

Shagun Singh

Thank first the then, get I on selling quarter. taking much and so you understanding great day know was QX? what for the in question guess to is, better of a I the you the wanted a And congratulations question, versus assuming support be year-to-date implied step It a weaker QX your outlook and are you that stronger. it you U.S. and that you're to in to assumes providing international hardware here. appears be U.S. surgical impact and performance, know down growth

be you the can for how buckets thinking we QX us you in know And of these give and the each should QX? takes about So segments XXXX? versus puts some then in

Rajesh Asarpota

Yes.

Okay.

is Thanks the So hey, question. Raj. this for

The Shagun is first question the X.X% of impact your quarter. day selling in the part

X.X% more So if hardware U.S. the business could that, you that rate at X.X%. business, is like it growth the grew think for normalize the about

think hardware in of we terms fourth I about quarter then the think business. the outlook, And the as

typical. midpoint which they quarter we fourth to X% reasonable. prudent the is far X.X% more Let's got comparable continue kind if just business normalize being of degradation, But price day, some the so that of be will of for guidance one take one bit a to at for U.S. a a extra time. robust. little again, hardware the roughly in to as account bit year-over-year your is is But selling our little And very terms you the think X.X%

I guidance, compared are growth comparable. it's hardware terms in to positive fair business, to the to being will that saying continue So prudent that, want by we very we say but the that of want we I and see in think

say be has we in did As that Pulse not fourth revenue not the surgical will expectation you any support at changed there quarter. materially. the business from But that look

growth flat X% market business essentially will biologics bit business segment a and there, of will to around like of track be the showing little that the growth, year, said. with biologics continue in of NCS little and a we So for kind with bit to showing

written international And in then goodness dynamics to States, pointed continuing business, as and a little the that terms Asia on said remarks United my a international bit the see the the think of availability a America side. I in terms we're constrained challenge out about of that's seeing that we Latin the in in of Pacific leveraging little bit in on

to a still that's growth going So that down bit. the for a step We'll little see in double-digit geography. year

that for year. the So quarter, and the essentially the is total fourth balance

Shagun Singh

shake Any buckets and out? color these on XXXX, how

Rajesh Asarpota

this No, not at point.

We will fourth that on our quarter earnings. report

Shagun Singh

Got for question if could squeeze one Chris. it. I just in And

know choice the Pulse was the German know wondering showcased know was you. industrial why robot robots. you features with what's what Thank just NAS which available. this was competitively collaboration and it of is system I this KUKA, the you some manufacturer your key right at and You in year, and differentiating is the are of between

Chris Barry

of shot. a take I'll Well bit a

that the our the all really of application think is of uniqueness I truly Pulse. integrated is system that

spine very the it I operative procedural having provides monitoring that Matt’s application, robotic inter much base. but a think broader framework earlier XD navigation, integrated a provides the in imaging, XD to and full imaging, point utilization across only not having the So a unique system

is got integrated represents the think modularity system to technology. what the I we've of Pulse truly but continue of the and our that robotic the I uniqueness application, a system broad the utilization competitive think opportunities platform very this to of software actually the So and

Shagun Singh

you. Thank

Chris Barry

Thank you.

Operator

Thank you.

the Please comes Matt question next Credit with Miksic Suisse. your proceed question. with from of Our line

Matt Miksic

earlier, you letting appreciate that back for sorry thanks happened. what sure Hey, I me in. not

So the One, through follow-ups. on I that of and the outlook and Raj the and couple it was beta feedback and progression for had you're getting. your Pulse a Pulse I comment think

next and maybe that if process gaining flush could maybe the commitments, then we if of It into that of you accounts you're committed process sort getting to upgrading expectations out, upgrading think like. rollout following us know and the have helpful I these what to the would sites? how just without through fit system parts sounds early could like be one the I maybe looks follow. they types very understand? the into one but have you walk of whose obviously or year And specifics,

Matt Link

that. Matt. is this Yes I'll take

was into a we entered with of expectation So and of to set QX, through which deploy integration the early as applications market had experience continue would that the Pulse applications of in validated first we gain all been interoperability. those alphas around

while all it's Pulse utility the applications. approved, validated about we’ve as and talked applications been so the And are platform, of the really around integration of

if think integration the you navigation planning of surgical and and monitoring about of XD So the deployment capabilities. interoperable both

work experience through to it commitments garner to moving been able and forward. associated in And advancement, software of placement been to a us with we've the continue gain so the of have through sites number doing body able to clinical the of that to so, allows pilot our betas units with a relevant

back half through the been intent has of the that the the so, year. And course of

and the around relative with XXXX. believe, we track contribution, we we provided have, for While remain on previously the some conservatism we guidance

Matt Miksic

end as that, down process it? that but to guess, sites rolling the final those I that be is to, upgrading and the on just that sites, seems early first kind don't I tail the you're you And recognize look of like say turn want we part understand those the involve the year, then want will -- do to I but revenue of throughout at of batch system it where you of the to likely to are

Matt Link

would you way it. But of look the I It’s of address want to directionally know a I at version it’s just the a a system. to final the sort -- articulate fair think how also we

policy, architecture we've about As talked talked that's a we’ve extensible. software about

of next that applications. course Our down we the several is continue the process anticipation years adding of over will a

inclusive we about applications and the roadmap Pulse, next when of and months, Pulse a robotics, those of available installation. with continual to so, part There's as applications then application would a installation And be made that course a system we release final XX of the diversion future gen. to available with of over be the like in XX will the next think the Pulse think a sites and associated today of on that don't

I of a system to again, an over is really the to I just way. deploy like that not at we quote version several directionally right endpoint. extensible the intend years. intended unquote with the next roadmap a It's the So final think would course characterize looking applications you're

Matt Miksic

point I then of follow hope this Raj that the on lot making trajectory there respect ask like that right up data, changes with of just sort A but I I feel but here, impacting stuff had helpful. that’s international I'm one the again, that I make. I'll then think the of is you're kind and be know growth, of here, to for you just the and making think investments And might there’s Sure Raj, make you is investments the you're the and to [Indiscernible].

show when Just more they the regionally might what to they shall timing maybe bit are, think maybe are a on return as you or little start you where color those to if you? and could for

Chris Barry

to Chris. from numerology. is keep going this Matt, Yes. I'm answering you

listen. So

international ability in the growth the some the impacted has of assets. to some of -- the equip markets the our with U.S. of honestly business Some fully

getting about and -- As make operating lot that you've company the and really up and a talk we're discipline. heard chain with rigour me supply our ensuring running and

time of have the had because Europe. that make markets either and over U.S. choices got primarily to we're of this said other foregone the sets sets. the deploying Western other that we course the seeing parts some we year our in as where in And of demand demand we're originally world, a to outstrips cases, we've I've and truly before And delivering in our thought, supply,

And fulfilled that less very response the good good the we've a delivering I key were with issues very set of with going to think that the those, starting and that over expected There AsiaPac when down we'll certain delivery some quarters in markets as year has that sets and in we've course certain out seen not continued news been of earlier over late like that's we're be XXXX than couple of was specifically quarter, related that But of the the that will the I on expected feel areas Brazil. guaranteed very customs we've the believe be inventory. Japan, with challenged growth all us. and been be this into last good majority to with

some So the of year. land on growth this lay U.S. that's international the in the we've that really market shifts of versus the seen

still out delivery I strategy. one still think we're the term we the, biggest for of in national of to August our that point, Raj’s believe growth. committed of the expectations New on York to laid I back expansion opportunities It's single the long in the

news, is we Just news, Bad the really fulfill to news moving in bit the good bad good a need more is, of opportunities term seeing a make growth strong little news been the U.S. short sets. Kind in challenging. has very to we're

So we're try that remedy working to on situation. that as to we speak

Matt Link

bit just has like know evolving And been and side, just the just really if for we're gone a on in robust had little little a certain a just the add We're little the super but international so bit The landscape off seeing of year We to best haven't the can expectations aggressive balance I then know our here. Chris some in shift away. growth doing we were that, you States, kind you geographies said. opportunities Yes. then a United outlook here. bit

as for Day. like as again, the So said future international talked see about expansion the Investor business, the continue we far to we you good during know we in

So…

Operator

you. Thank

from question David Please proceed Lewis the next of line your Our Stanley. with comes Morgan question. with

David Lewis

Chris, then one for just and for question. Good falls afternoon. Raj. for you taking some Thanks the

for relative placements, full of sort the whether purchase be, other activity, clarity kind questions based use sales Pulse And in quarter deal or would do and one about have that's of company, should XXXX kind as quarter you plan? a agreements, Pulse, the curious of we should Raj? to on tracked think any quick we cash terms first thinking commercial be sort structure, and the how of then the just I'm for beta post a of of the Just greater

Chris Barry

consistent David. guess -- the expected. activity has Okay. The been the some for question. Yes the Thanks velocity of the what thanks, PO we I of

capacity press trying our necessarily to we full haven't court we've again, a Now put on this. of because commercialize fully internal

the we've system taken So we've customers that to. pretty selective been on

have last consistent. wouldn't approached been so to the been over that's So customers over but We've intentional. process I to that the concerned, say the have obviously that the those the the grown actually haven't actually be pipeline through several are POS that end, last on expectations say overcommitted. transitioned say through I’d it's PO, consistent, certain from we've months, The and very substantially but I general a several is development. would exceeding that's pipeline we my they POS,

the your will which as far as part ways these as next of your units. sell question, far As or in place we

can. flexible key is the and to as I this we I before, think said as be

We are. to willing to meet commitment. to portfolio on out get have on Obviously, our take We're a that build I'm purchases. ways one ensure willing our where of take we for they to financial POS arrangements to can I'm some continuing creative installed. customers capital

place to keeping a open driving also are well covering with So of that broader we're these but very is aspect POS keen the and the Pulse that system. eye both represented the keeping we're procedures in ensuring we proceduralization portfolio these mind a on how

Based is the be on be first your to as believe, tricky. in for would is we curve XXXX, I question learning good going just I quarter have or that What when commercialization to we systems servicing installing keep I the us that getting an organization. capacity full will these a is we far As consider internal these installing a the will commercialization. fact the -- that, as have eye upon we are have a bit I systems an to, last that bit on say system at and XXXX.

our way, would that out really go gating a of in deliberate to of time. commercialization we're that very So period a number on certain over end, our certain a taking systems only

of to for and that about we'll work talking we solidify forward will stages the XXXX the as more through the beta, at plans So quarter. we look final end of fourth our

David Lewis

performance But you. towards Very year, the end, sort basis historical this perspective. of the for margin day thinking top if XX you're a cycling of of points fourth LRP obviously conservatively Chris. maybe trend. earnings the just the again, look one kind it to points from margin at of XX first helpful looks for quarter Raj, then tracking sort then the a more quick kind of at We an model perspective very and back and two on I years from the frankly basis Hi analyst your half perspective, look left loaded a XX and versus the year, I and

we the be XXXX of to we margin think so still that how So trajectory in half in first at should XX be and made gave the thinking half XX date plan, in basis points or beyond? the you of the the thinking has you much. plan, stay? about bigger annual about or the second differently margins progress Should Thanks to

Rajesh Asarpota

that be No us. the that of thinking in said and terms Yes. are in the that ahead We've regard. very investments of delivering kind growth balancing change in we will of opportunistic that

through the the expect some for we've taken US said, been which of let only guidance our So I up primarily guidance be And that's obviously right we it the hardware year. expectation. up. and like goodness this for margin flow fourth taken In kind year, quarter, for year, around to we’ve in the appropriately growth year the the from next

chain, packaging the talking some be -- heavy that's in MDR, are out those ERP finishing that terms The about been investments needs supply and lifting to some still of that still done. the we've sterile have infrastructure

you see we've we will regress. will like said, So not

is We what end It's you loaded, see be the just over will back year a so. expansion. to deliver than rhythm going that margin more on next or

around more hasn't bit general guidance, the it But would stay XXXX But tuned color for that. again, changed. be a specific little

Operator

Thank you.

comes Newitter the proceed question with Richard your next Leerink. Please line with SVB Our question. of from

Richard Newitter

for between taking so calls, Jumping Thanks been asked. Hi. something's I my apologize. questions.

Just U.S. October. we've talking there? about you rollout, but plans a first got I back approval what I been Pulse. you EU said think on know about the in launch

what international the curious Then plans I Just of for have rollout that are follow a product? the up.

Matt Link

mentioned is rollout similarly the site ensure line had of script being the handful those Matt. Zealand. evaluation, earlier centers support in in in capacity targeted infrastructure that we Similarly to to rollout there U.S. the the with specific It's markets it's have the Yes, as and trials, judicious much as New installation international across Europe, and Australia, in well service. a We

XXXX. have in through of in course the place scale part in a appropriately. a we're I QX about should scaled Europe in all said, have team the you think States. the And we similar that to we United deployment relatively that forward move mirrors the U.S. So prepared the into but team And appropriately, that of that late first manner to

Richard Newitter

give division moving know I maybe Got it. a little been to of because a is. probably a -- much that that it's on taking you're And reluctant know that the too a little XXXX, given headwinds you are some just biologics that bit to turn. it little you longer call just turnaround but the of And

we just XQ recovery longer. maybe little Or now, be improve continuing XXXX, right thinking we out of a should think is the it of standpoint. is I should is we XXXX, throughout from bit and know think XXXX. that? there would As just modeling is of from kind helpful about there that a calling thinking biologics dynamics growth, be you're to it How the you continues that and be into then

Chris Barry

Yes.

So is your commentary we recovery. right expect continued on,

growth an I AttraX. within including think as mix script, in we're in as off his Raj continued biologic portfolio, seeing CSL and our as from associated products volumes BBM shift to well mentioned propelled in other

get And heading modest so we relatively QX. modest XXXX you could We I into greater into see think XXXX, in when being for we'll guidance that stable the growth, certainly think about growth address year. detail expect to is growth,

Operator

Thank you.

your Our proceed next question Marcus JPMorgan. of from question. Please with Robbie comes with the line

Robbie Marcus

me. questions for lot. a And a good Two Thanks Great. quarter. congrats on

here. little XX bps was more lowered you've of could the question was on a you year, a that the was more I which in color there by -- EBITDA XX bps just of P&L saw adjusted for First, that was? wondering I what loss strategic investment. on if release give press a

Rajesh Asarpota

Yes.

favorability in offset some we're seeing in based EBITDA. comp, other which stock is mean, investments by explanation look the on So OpEx. the being I

compared to that's That's, So on but a EBITDA. all operating it it's your there's that no expectations impact and is. margin, adjusted headwind slight

Robbie Marcus

wondering the quarter, you share? really And might had I is? you We spend think from? on be you're implant I in Okay. could gaining saw talk And minute spine gaining if this appreciate it. think quarter Stryker this there? and was how get stumble did any growth. where you sustainable some you Who a dynamics you about you then this pickup good it do integration, market

Matt Link

It’s Matt.

commented the of particular on we we including key segments, share procedural pleased in the of and ALIF continued single we're to we as training a progress. focus and education. subset a see are with So XXXX the I of physician and correlated XXXX. those as directly adoption in to The lateral XLIF has investment And see result think surgery solution a gains that a little earlier, bit certain

advancements out driven the We've our execution. growth both antibody Porous with portfolio, by on key Modulus posterior so AMS technology. and in curriculum been both interbody, posterior pleased deployment and and fixation thoracolumbar being Cohere procedural And primarily specifically focused PEEK to the very commercial program segments, other again, development including and posterior build fixation, continuing continued portfolio

that's consistent expectations. that's with been So been

pediatric inclusive into then as well of and continued And push deformity a both the complex, market. and deformity the for as really segment adult EOS complex surgery

long under portfolio. highlighted, there's for say addressing important the is from new penetrated QX moving launch. I'd there's both will say gains posterior alphas of and Research our the cervical in investing a an for growth segments. Chris strategy of Alpha's as the anterior script be forward commercial portfolio. in further be both instances, be as entering for great looking half been, been NuVasive. and steady across part terms In year XXXX solutions the upcoming solutions. Spine full In highlighted segment So those I opportunity first we’ll in is Society at that of into that's cervical We through meeting. And term five the We'll Cervical into QX,

variations market market presented terms gains. opportunities market we see opportunity geographic and market market from equally of share respect to itself segments it's the potentially say and disruption. across With in in there's I'd relatively general, where

from coming with Again, or wouldn't that see and competitor. stable of commercial plans that So XXXX. we with and expect to in their remain teams I've geographic our been suggest one the execution consistent U.S. heading area it necessarily any the into focus our pleased the we disproportionately

Operator

you. Thank

the Our next from with Matt line question your Taylor comes with UBS. of question. Please proceed

Unidentified Analyst

robotic or in level customers? ability funnel, arm for talk This Matt. from any the the Thanks robotic system Can question. on for upgrade Maybe post modularity is about if impact follow and guys. the the you question. [Indiscernible] post on interest taking NASS Hey just the on to [Indiscernible] the customers made and the of up to administrators and playing hospital

Chris Barry

mean, from definitely I it's having gaining interest customers.

administrators dollars, their into the it's for of the fully maximize, a trying think the as capital move NASS. we're maximize hospital had with critical, I eyes I of the point several their minimize lot hospital obviously nature had to the value think view of us Obviously, and I it's But, I comment and launch application. facility, the not surgeon too early leverage We capital a that integrated is many technology yet, that performs. upon we're at driver to investors we the a -- and it's think selling administrators and -- the the it critical trying a truly to is that utilization the will we system partners burden robotic to how Pulse obviously will in the and and for filling market. market on think understand so come they us yet

You is the us. that spine, back played resonates more need in hearing system and I with our that think we're to of know representative full a having customers

hospital early So surgeons, I only not it's the with administrators feel opportunity very the encouraged from by we’re getting response days, broader very, but the I’m system. but around

Operator

Thank you.

Ryan Our Zimmerman your proceed question. BTIG. with next comes Please question of line from with the

Ryan Zimmerman

on for And the squeeze congrats him Thanks in. quarter.

question, and and two Just me, a first XXXX. on housekeeping one for second one

to driving result per talk org on it of a maybe that some there but about is up or kind know as the XXXX so incremental maybe expenses revenue cases. Chris, sounds case ask briefly speak kind then And lot and you adoption onetime of you I'll as these quick it's any like of but much on structure could not the Raj, of change? dollars picking Matt quantitatively, Just of well this, a second question you're

If is getting closer on to incremental were it know $X.XX every you XX. somewhere dollar, you

on what gave what's Thanks should just of going And know that you you again, metric appreciate of cadence you qualitatively XXXX the taking on to training you and durability for going that you're cadence that a say of you about what's how numbers, not are know the and or quantity into surgeons that. can add, or And about where not you training that appreciating we then, XXXX, beyond? durability trained give think question. the know but that

Rajesh Asarpota

Hey Ryan.

So from the end, simple is my answer No. from my

the to one and it turn On of timers, I’ll it, for Matt. then the towards rest

Matt Link

I think, I've got everything here.

the to Without So able address the case of is, benefit comprehensively. with the I what specifics respect to are spine upside, think are the. in position values, getting of XXXX the you into lateral

couple a So capture for really a perspective. that beneficial state of from it does are us things

a to ability entirely. could or was a customer it's potential alternative they is that indication lateral of another another capture level possible overall do an that lateral, contraindicated levels if solution solution a for there the First, constant a procedure as surgery for perhaps use at more

benefit. one that's So

spine virtue by circumferentially. is of being other The address the to able

see there's leakage posterior perspective. any from So a lateral single all a likelihood fixation your type of or and less into that within of attachment position loss we

XXXX providing we that so the surgery Chris focused see so the that we moving combined case, referenced focusing the technologies on value forward. seeing trend incremental solution and that earlier, a enabling with patient as a are benefit. Pulse and to pathology. associated and comprehensive for And provide the to on integrating And very proceduralization solution intended those with I'll be an really and underlying

percentage represents durability, to small overall the in respect of relatively With a market, total antibody lateral antibody.

market attracted additionally within solution we conversions, other of of we durability of think I are users XXXX. this to for not competitive when lateral excellent pathway antibodies role laterally number existing towards And antibody of so expanding training Those positive increasing is and see traditional the education customer being durability to base, technology, comprehensive the the traction growth. good increasing the see and just the very and but a while more posterior the our in lateral see and of therefore utility total we really type of lateral relative users surgery

you focused for a commercial to our vital targeting and so support shift activities, XXXX in imagine, provide invasive believe that model we're we're as very just as service we training to And and less well and interventions organization surgery general, creating clinical significant benefit. their which can alignment economic and through on surgical that education technology and ensuring as solution aligning

Operator

closing turn Mr. Barry, back session. for question-and-answer the to like we've you reached I'd call to the end of the over remarks.

Chris Barry

thanks all And Thanks. for today. us joining

joining. QX. of very As or hear end seeing Thanks the forward pleased again I you with again how for the look said, gone. all I'm at to has quarter you I from

Operator

Thank teleconference. you. This concludes today's

your this wonderful may disconnect You lines day. at your for you Thank a have participation, time. and

Nuvasive (NUVA) 30 Oct 192019 Q3 Earnings call transcript